Anatara Lifesciences Ltd ANR.AX Stock
Anatara Lifesciences Ltd Price Chart
Anatara Lifesciences Ltd ANR.AX Financial and Trading Overview
| Anatara Lifesciences Ltd stock price | 0.04 AUD |
| Previous Close | 0.03 AUD |
| Open | 0.03 AUD |
| Bid | 0.03 AUD x 0 |
| Ask | 0.03 AUD x 0 |
| Day's Range | 0.03 - 0.03 AUD |
| 52 Week Range | 0.03 - 0.08 AUD |
| Volume | 26.19K AUD |
| Avg. Volume | 61.56K AUD |
| Market Cap | 3.12M AUD |
| Beta (5Y Monthly) | 0.831334 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANR.AX Valuation Measures
| Enterprise Value | 1.77M AUD |
| Trailing P/E | N/A |
| Forward P/E | 1.3000001 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 40.41404 |
| Price/Book (mrq) | 1.7333333 |
| Enterprise Value/Revenue | 22.922 |
| Enterprise Value/EBITDA | -0.772 |
Trading Information
Anatara Lifesciences Ltd Stock Price History
| Beta (5Y Monthly) | 0.831334 |
| 52-Week Change | -55.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 AUD |
| 52 Week Low | 0.03 AUD |
| 50-Day Moving Average | 0.03 AUD |
| 200-Day Moving Average | 0.04 AUD |
ANR.AX Share Statistics
| Avg. Volume (3 month) | 61.56K AUD |
| Avg. Daily Volume (10-Days) | 89.11K AUD |
| Shares Outstanding | 119.92M |
| Float | 77.57M |
| Short Ratio | N/A |
| % Held by Insiders | 31.18% |
| % Held by Institutions | 8.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2975.66% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -56.45% |
| Return on Equity (ttm) | -105.16% |
Income Statement
| Revenue (ttm) | 77.15K AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | 24.19% |
| Gross Profit (ttm) | -747181 AUD |
| EBITDA | -2290125 AUD |
| Net Income Avi to Common (ttm) | -2294200 AUD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.4M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 55.62K AUD |
| Total Debt/Equity (mrq) | 3.24 AUD |
| Current Ratio (mrq) | 9.164 |
| Book Value Per Share (mrq) | 0.015 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2383521 AUD |
| Levered Free Cash Flow (ttm) | -1527172 AUD |
Profile of Anatara Lifesciences Ltd
| Country | Australia |
| State | SA |
| City | Adelaide |
| Address | 81 Flinders Street |
| ZIP | 5000 |
| Phone | 61 3 9824 5454 |
| Website | https://anataralifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Adelaide, Australia.
Q&A For Anatara Lifesciences Ltd Stock
What is a current ANR.AX stock price?
Anatara Lifesciences Ltd ANR.AX stock price today per share is 0.04 AUD.
How to purchase Anatara Lifesciences Ltd stock?
You can buy ANR.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anatara Lifesciences Ltd?
The stock symbol or ticker of Anatara Lifesciences Ltd is ANR.AX.
Which industry does the Anatara Lifesciences Ltd company belong to?
The Anatara Lifesciences Ltd industry is Biotechnology.
How many shares does Anatara Lifesciences Ltd have in circulation?
The max supply of Anatara Lifesciences Ltd shares is 167.89M.
What is Anatara Lifesciences Ltd Price to Earnings Ratio (PE Ratio)?
Anatara Lifesciences Ltd PE Ratio is now.
What was Anatara Lifesciences Ltd earnings per share over the trailing 12 months (TTM)?
Anatara Lifesciences Ltd EPS is -0.01 AUD over the trailing 12 months.
Which sector does the Anatara Lifesciences Ltd company belong to?
The Anatara Lifesciences Ltd sector is Healthcare.